Selecta Biosciences Receives $4,450,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b6cd9c98-feb6-4e65-bb05-41a5a3985869 - Date
8/29/2014 - Company Name
Selecta Biosciences - Mailing Address
480 Arsenal St. Building One Watertown, MA 02472 USA - Company Description
Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. - Website
http://www.selectabio.com - Transaction Type
Venture Equity - Transaction Amount
$4,450,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
